Cargando…
Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
BACKGROUND: Laminin-α2-related congenital muscular dystrophy (LAMA2-CMD) is a devastating genetic disease caused by mutations in the LAMA2 gene. These mutations result in progressive muscle wasting and inflammation leading to delayed milestones, and reduced lifespan in affected patients. There is cu...
Autores principales: | Barraza-Flores, Pamela, Hermann, Hailey J., Bates, Christina R., Allen, Tyler G., Grunert, Timothy T., Burkin, Dean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271547/ https://www.ncbi.nlm.nih.gov/pubmed/32498713 http://dx.doi.org/10.1186/s13395-020-00235-4 |
Ejemplares similares
-
Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics
por: Barraza-Flores, Pamela, et al.
Publicado: (2020) -
A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD
por: Gawlik, Kinga I., et al.
Publicado: (2020) -
Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients
por: Kölbel, Heike, et al.
Publicado: (2019) -
Laminin-111-derived peptides and cancer
por: Kikkawa, Yamato, et al.
Publicado: (2013) -
Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain
por: Dai, Jinxiang, et al.
Publicado: (2022)